| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 08/19/1999 | WO1999024074A3 Novel conjugates of opioids and endogenous carriers |
| 08/19/1999 | WO1999016419A9 Perforated microparticles and methods of use |
| 08/19/1999 | WO1999014355A3 Highly affine nucleic acid molecules, production and application of same |
| 08/19/1999 | WO1999001162A3 Diagnostic method for the detection of miocardial ischemia |
| 08/18/1999 | EP0935654A1 Fibroblast growth factor homologous factor-3 (fhf-3) and methods of use |
| 08/18/1999 | EP0935442A1 Instrument having enhanced ultrasound visibility |
| 08/18/1999 | EP0762899A4 Stabilized homogenous suspensions as computed tomography contrast agents |
| 08/18/1999 | EP0651799B1 Fibrin binding domain polypeptides and uses and methods of producing same |
| 08/18/1999 | CN1226147A Method for inproving selectivity in photo-activation and detection of molecular diagnosis agents |
| 08/18/1999 | CN1225922A Metal chelates of substituted polyaminocarboxylic macrocycles and their use in diagnostic imaging |
| 08/17/1999 | US5939073 Fish pancreatic disease virus |
| 08/17/1999 | US5939046 Method of evaluating an effect of a substance applied to the skin of a mammal |
| 08/17/1999 | US5939045 Prepared by reacting a reactive magnesium organic compound with a trihalobismuth compound |
| 08/17/1999 | CA2042722C Polymeric gas or air filled microballoons usable as suspensions in liquid carriers for ultrasonic echography |
| 08/13/1999 | CA2261255A1 Assessment of ischemic wound healing therapeutics |
| 08/12/1999 | WO1999040111A1 The aiolos gene |
| 08/12/1999 | WO1999039748A1 Targeting immunoreagents useful in therapeutic and diagnostic compositions and methods |
| 08/12/1999 | WO1999039747A1 Bipapcitide-based pharmaceutical compositions for imaging and treating thrombi |
| 08/12/1999 | WO1999039745A1 Contrast medium based on polyoxethylene-660-12-hydroxystearate and anionic phospholipids |
| 08/12/1999 | WO1999039738A1 Targeted delivery of biologically active media |
| 08/12/1999 | WO1999039693A2 Methods and compositions for detection and diagnosis of infectious diseases |
| 08/12/1999 | WO1999008716A3 Process for preparation of lyophilised contrast agents |
| 08/12/1999 | WO1998052617A3 Contrast media for imaging of lung draining lymph nodes, administered through the lungs |
| 08/12/1999 | DE19805012A1 Kontrastmittel zur Verwendung als Diagnostikum bei bildgebenden Verfahren sowie seine Herstellung Contrast agent for use as a diagnostic agent for imaging and its preparation |
| 08/11/1999 | EP0934986A1 Dye-polysaccharide or -cyclosaccharide conjugates and their use as diagnostic agent |
| 08/11/1999 | CN1225591A Membrane incorporation of texaphyrins |
| 08/10/1999 | US5935942 Co-administering a fluorescent dye encapsulated within a heat-sensitive liposome and tissue reactive agent activated by irradiation, selectively heating, monitoring, activating by irradiating |
| 08/10/1999 | US5935866 Preparing inorganic oxides of substantially uniform particle size distribution by mixing aqueous solutions of metal (2+) and metal (3+) inorganic salts and inorganic base across porous membrane, precipitation of oxides; for immunoassays |
| 08/10/1999 | US5935820 Polynucleotides encoding vascular endothelial growth factor 2 |
| 08/10/1999 | US5935553 Methods of preparing gas-filled liposomes |
| 08/10/1999 | US5934103 Method and apparatus for production of spin-polarized medical-grade xenon 129 gas by laser optical pumping |
| 08/05/1999 | WO1999038870A1 Compounds containing boron for electron microscopy and for boron neutron-capture therapy |
| 08/05/1999 | WO1999038538A1 Mri contrast agents comprising ethylene diamine disuccinic acid as chelants |
| 08/05/1999 | WO1999038500A2 The human calcium-sensing receptor in the detection and treatment of cancer |
| 08/05/1999 | WO1999024472A3 Glycosylated antibodies and antibody fragments having reactive ketone groups |
| 08/05/1999 | WO1999019359A8 Cellular receptor for hiv-1 vpr essential for g2/m phase transition of the cell cycle |
| 08/05/1999 | WO1995031429A8 Photocleavable agents and conjugates for the detection and isolation of biomolecules |
| 08/04/1999 | EP0932419A2 Stabilized microparticles and their use as ultrasound contrast agents |
| 08/04/1999 | EP0810989B1 Novelly substituted dtpa derivatives, metal complexes thereof, pharmaceuticals containing these complexes, diagnostic and therapeutic uses thereof and methods for preparing the complexes and pharmaceuticals |
| 08/04/1999 | EP0644775B1 Cocaine Receptor Binding Ligands |
| 08/04/1999 | EP0642761B1 Ct system for quantitatively determining bone mineral mass |
| 08/04/1999 | CN1224622A Tumor target direction contrast agent |
| 08/03/1999 | US5932470 Ectoparasite saliva proteins and apparatus to collect such proteins |
| 08/03/1999 | US5932190 Multinuclear complexes for X-ray imaging |
| 08/03/1999 | US5932188 Therapeutic and diagnostic imaging compositions and methods |
| 07/29/1999 | WO1999037683A1 MONOCLONAL ANTIBODY ANTI αv-INTEGRIN AND ITS USE TO INHIBIT αvβ6-INTEGRIN ATTACHMENT TO FIBRONECTIN |
| 07/29/1999 | WO1999037142A1 Method for producing transgenic animals |
| 07/29/1999 | CA2319160A1 Monoclonal antibody anti .alpha.v-integrin and its use to inhibit .alpha.v.beta.6-integrin attachment to fibronectin |
| 07/28/1999 | EP0930897A2 Method |
| 07/28/1999 | EP0930844A1 Improved methods for diagnostic imaging by regulating the administration rate of a contrast agent |
| 07/27/1999 | US5929299 Helicobacter pylori-colonized mongolian gerbils, method for preparation thereof, and method for screening anti-Helicobacter pylori substance using them |
| 07/27/1999 | US5929212 CD3 specific recombinant antibody |
| 07/27/1999 | US5929105 Ethylene glycol esters as photoactive agents |
| 07/27/1999 | US5928958 Superparamagnetic particles, process for their manufacture and usage |
| 07/27/1999 | US5928669 Lymphatic delivery methods |
| 07/27/1999 | US5928627 Fluorescent chelates as visual tissue specific imaging agents |
| 07/27/1999 | US5928626 Contrast agents, consisting of carbohydrate particles |
| 07/27/1999 | US5928625 Using detectable agent of fluorescin-labeled succinylated polylysine dye |
| 07/22/1999 | WO1999036104A2 Preparation of a lipid blend and a phospholipid suspension containing the lipid blend, and contrast agents based on these |
| 07/22/1999 | WO1999018998A3 Delivery system |
| 07/22/1999 | WO1998046276A8 Chelating agents |
| 07/21/1999 | EP0929319A1 Dopamine and serotonin transporter ligands and imaging agents |
| 07/21/1999 | EP0929303A2 Cns-penetrant nk-1 receptor antagonists as antidepressant and/or an anti-anxiety agent |
| 07/21/1999 | CN1223685A Modulators of tissue regeneration |
| 07/21/1999 | CN1223592A Fluoro labelled anthracyclinone and anthracycline derivatives |
| 07/21/1999 | CN1223145A Carcinoembryonic antigen gene engineering antiboy CL-3-scFv |
| 07/20/1999 | US5925730 Decapeptide gonadotrophin releasing hormone antagonists; for antifertility agents especially for males; precocious puberty; dysmenorrhea; antitumor/anticarcinogenic agents; endometriosis |
| 07/20/1999 | US5925332 Radioimaging and radiochemotherapy phenolic thioether amines and acyl derivatives thereof for use in diagnosing and treating pigmentation disorders |
| 07/15/1999 | WO1999035508A1 Method of magnetic resonance investigation |
| 07/15/1999 | WO1999035292A1 Compositions and methods for treating cells having double minute dna |
| 07/15/1999 | WO1999035241A1 Transgenic rabbit that expresses a functional human lipoprotein (a) |
| 07/15/1999 | WO1999035160A1 Human fk506 binding proteins |
| 07/15/1999 | WO1999035134A1 1,4,7,10-tetraazacyclododecane-1,4-diacetic acid |
| 07/15/1999 | WO1999035133A2 1,4,7,10-tetraazacyclododecane-1,4-diacetic acid derivatives as chelating agents |
| 07/15/1999 | WO1999034829A1 Embolizing compositions comprising surfactants |
| 07/15/1999 | WO1999034827A1 Activated t-cells and their uses |
| 07/15/1999 | WO1999034779A1 Magnetically responsive composition |
| 07/15/1999 | WO1999025857A3 Transgenic models of inflammatory disease |
| 07/15/1999 | WO1999024391B1 Radio-opaque polymer biomaterials |
| 07/15/1999 | CA2318435A1 Human fk506 binding proteins |
| 07/15/1999 | CA2318380A1 Compositions and methods for treating cells having double minute dna |
| 07/14/1999 | EP0928809A1 Polysaccharide derivative/magnetic metal oxide composite |
| 07/14/1999 | EP0928611A1 Medical powder |
| 07/14/1999 | EP0928203A1 Gene therapy for inhibition of angiogenesis |
| 07/14/1999 | CN1222860A Microencapsulated fluorinated gases for use as imaging agents |
| 07/13/1999 | US5922355 Composition and method of preparing microparticles of water-insoluble substances |
| 07/13/1999 | US5922304 Gaseous precursor filled microspheres as magnetic resonance imaging contrast agents |
| 07/13/1999 | US5922302 Detection and therapy of lesions with biotin/avidin-metal chelating protein conjugates |
| 07/08/1999 | WO1999034189A2 Process and device to solidify and thaw a polarized gas comprising xenon |
| 07/08/1999 | WO1999033492A1 Method for tissue perfusion |
| 07/08/1999 | WO1999019466A3 Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities |
| 07/08/1999 | WO1999011604A9 Sterilized 5-aminolevulinic acid |
| 07/08/1999 | CA2315092A1 Method for tissue perfusion |
| 07/07/1999 | EP0927758A2 Recombinant antibodies specific for TNF-Alpha |
| 07/07/1999 | EP0927558A1 Embolizing compositions comprising surfactants |
| 07/07/1999 | EP0927049A2 Labelled elastase inhibitors |
| 07/07/1999 | EP0927048A2 Marker compositions |
| 07/07/1999 | EP0927047A2 Use of hollow microcapsules |
| 07/07/1999 | EP0728019A4 Labelled diagnostic compositions and methods of their use |
| 07/07/1999 | EP0585412B1 Increasing blood-brain barrier permeability with permeabilizer peptides |